HARTUNG; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for HARTUNG; Thomas.The latest application filed is for "radiolabeled compounds".

Company Profile

4.11.14

HARTUNG; Thomas - Lorrach DE
Hartung; Thomas - Loerrach DE
Hartung; Thomas - Baltimore MD
Hartung; Thomas - Constance N/A DE
Hartung; Thomas - Augsburg N/A DE
Hartung; Thomas - DE-78462 Konstanz DE
Hartung, Thomas - Konstanz DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Radiolabeled Compounds App 20220202963 - COLLIN; Ludovic ; et al.	2022-06-30
Synthesis Of Trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene And Crytalline Forms Thereof App 20210284648 - Rothenhaeusler; Benno ; et al.	2021-09-16
Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H- -2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereof Grant 11,040,977 - Rothenhaeusler , et al. June 22, 2	2021-06-22
Compositions And Methods For Neuralgenesis App 20200121725 - Hartung; Thomas ; et al.	2020-04-23
Synthesis Of Trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene And App 20190194210 - Rothenhaeusler; Benno ; et al.	2019-06-27
Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H- -2,3,5,10B-tetraaza-benzo[E]azulene and crytalline forms thereof Grant 10,246,460 - Rothenhaeusler , et al.	2019-04-02
Radiolabeled cannabinoid receptor 2 ligand Grant 10,227,308 - Ametamey , et al.	2019-03-12
Biological system to test in vitro if a substance is immune reactive Grant 9,784,753 - Wendel , et al. October 10, 2	2017-10-10
Radiolabeled Cannabinoid Receptor 2 Ligand App 20170166534 - Ametamey; Simon M. ; et al.	2017-06-15
Synthesis Of Trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo- [e]azulene And Crytalline Forms Thereof App 20160280712 - Rothenhaeusler; Benno ; et al.	2016-09-29
Radiolabeled Compounds App 20160031878 - BORRONI; Edilio ; et al.	2016-02-04
Ink-saving ink supply of printing machines Grant 8,398,192 - Hartung March 19, 2	2013-03-19
Method For Determining Substance Non-toxicity App 20130005588 - Hartung; Thomas	2013-01-03
Radiolabelled inhibitors of the glycine 1 transporter Grant 8,153,679 - Alberati , et al. April 10, 2	2012-04-10
Ink-Saving Ink Supply of Printing Machines App 20110001774 - Hartung; Thomas	2011-01-06
Method for assaying flowing media for microbial toxins Grant 7,745,107 - Hartung June 29, 2	2010-06-29
Radiolabelled Inhibitors Of The Glycine 1 Transporter App 20100111862 - Alberati; Daniela ; et al.	2010-05-06
Device for Supplying Ink to a Printing Press App 20080014101 - Hartung; Thomas ; et al.	2008-01-17
Process for the preparation of the PPAR alpha agonist NS-220 App 20070197615 - Hartung; Thomas ; et al.	2007-08-23
Test procedure with biological system App 20050090020 - Wendel, Albrecht ; et al.	2005-04-28
Method for assaying flowing media for microbial toxins App 20040161766 - Hartung, Thomas	2004-08-19
Test for determining pyrogenic effect of a material Grant 5,891,728 - Wendel , et al. April 6, 1	1999-04-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.